J&J has received the US FDA approval for Rybrevant Faspro, a SC administered therapy to treat patients with EGFR-mutated ...
The Mid-South health system identified over twice as many incidental pulmonary nodules, half of which were in a higher-risk ...
Grant funding will advance pediatric lung and spine researchPHOENIX, Dec. 18, 2025 /PRNewswire/ -- Phoenix Children's ...
Long after their active duty ends, many veterans in North San Diego County, California, continue to shoulder the health risks ...
Animal Models Show Full Protection Against Omicron Variant Despite Absence of Neutralizing Antibodies, Highlighting Critical Importance of T-cell Immunity for Next-generation COVID-19 Vaccines ATLANTA ...
News-Medical.Net on MSN
Study finds a new protein target against KRAS-driven non-small cell lung cancer
In a study published in The Journal of Clinical Investigation, University of Michigan researchers found a new protein target ...
When surgeons remove an aggressive bone tumor from the pelvis, saving a patient's life can mean sacrificing a large portion ...
Biomarker Therapy in 2025: More Lung Cancer Options, Competition in New Drug Classes, ctDNA Advances
This year, there was a surge of new lung cancer treatments, more options for patients with earlier-stage disease, and growing ...
Mepolizumab reduced COPD exacerbations in patients with eosinophilic inflammation, highlighting the potential of ...
Lung development begins during embryogenesis and continues after birth. It includes branching of airways, formation of ...
Each year, CBS News Chicago remembers some of the many people who made the city tick through a variety of talents and ...
Originally classified as ‘junk DNA’, genomic regions which are transcribed into RNAs that do not serve as template for protein production have attracted increasing attention in the last two decades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results